濮陽惠成(300481.SZ)擬變更部分募集資金 用於收購山東清洋
格隆匯12月12日丨濮陽惠成(300481.SZ)公佈,根據公司發展戰略,結合行業發展變化,為了提高募集資金使用效率,公司擬變更“年產1萬噸順酐酸酐衍生物擴產項目”的募集資金用途,用於收購山東清洋新材料有限公司100%股權,並終止原募投項目。
考慮到“年產1萬噸順酐酸酐衍生物擴產項目”尚未開始資金投入,為提高募集資金使用效率,提升股東投資收益,公司擬終止“年產1萬噸順酐酸酐衍生物擴產項目”,將該項目尚未使用的募集資金6108.61萬元及其利息(最終金額以股東大會批準後實際轉出時銀行結息金額為準)用於收購山東清洋新材料有限公司100%股權,金額不足部分以公司自有資金或自籌資金投入。
此次擬收購對象山東清洋具有年產10000噸甲基四氫苯酐和5000噸甲基六氫苯酐的產能,並且擁有相關發明專利。鑑於標的公司具備順酐酸酐衍生物1.5萬噸的產能,與“年產1萬噸順酐酸酐衍生物擴產項目”產能一致,因此,公司擬終止自建“年產1萬噸順酐酸酐衍生物擴產項目”,變更募集資金投資項目用於收購標的公司股權。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.